Free Trial

Cresco Labs Q4 2022 Earnings Report

Cresco Labs logo
$0.95 0.00 (0.00%)
(As of 12/17/2024 ET)

Cresco Labs EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.02
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Cresco Labs Revenue Results

Actual Revenue
$199.58 million
Expected Revenue
$204.47 million
Beat/Miss
Missed by -$4.89 million
YoY Revenue Growth
N/A

Cresco Labs Announcement Details

Quarter
Q4 2022
Time
Q4 2022 Earnings Release

Conference Call Resources

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available 

Cresco Labs Earnings Headlines

Cresco Labs FY2025 EPS Estimate Lifted by Atb Cap Markets
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Cresco Labs (OTCMKTS:CRLBF) Cut to Hold at Atb Cap Markets
Cresco Labs downgraded to Market Perform from Speculative Buy at Cormark
See More Cresco Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email.

About Cresco Labs

Cresco Labs (OTCMKTS:CRLBF), together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

View Cresco Labs Profile

More Earnings Resources from MarketBeat

Upcoming Earnings